Skip to main content
logo
Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.3031
+0.0121 (4.16%)
At close: Nov 4, 2026, 4:00 PM EST
0.3075
+0.0044 (1.45%)
After-hours: Nov 4, 2026, 7:15 PM EST

Mereo BioPharma Group Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
----0.5-----1-9-------
Revenue Growth
--------------------
Gross Profit
----0.37-----1.270.245.570.350.360.380.210.230.160.15
Operating Income
-6.91-8.67-7.62-9.87-9.75-11.02-14.7-9.15-12.45-9.42-7.05-8.99-0.19-10.91-13.21-14.2-13.25-14.33-14.04-14
Net Income
-7.01-6.72-7.35-7.02-14.62-12.89-7.05-15-12.26-8.95-9.11-6.53-1.75-12.08-9.57-10.44-11.64-12.590.430.43
Earnings Per Share
-0.04-0.04-0.05-0.04-0.09-0.08-0.05-0.10-0.09-0.06-0.07-0.05-0.01-0.10-0.08-0.09-0.10-0.11-0.14-0.14
EPS Growth
--------------------

Cash & Debt
Chart
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Cash & Investments
30.1236.2240.9948.756.1362.4869.880.5287.4348.6657.4253.5253.5268.1868.1868.1892.85100.45127.68127.32
Total Debt
1.03-0.20.40.60.756.436.686.166.025.9511.8311.8315.3715.3715.3721.8623.6522.6922.63
Net Cash (Debt)
29.0936.2240.7948.355.5261.7463.3773.8481.2742.6451.4741.6841.6852.8152.8152.817176.8104.99104.69
Net Cash Growth
-47.61%-41.33%-35.63%-34.59%-31.68%44.78%23.13%77.15%94.97%-19.26%-2.54%-21.07%-41.29%-31.24%-49.70%-49.55%-42.55%-37.70%1289.80%1363.11%
Net Cash Per Share
0.180.230.250.300.350.390.410.480.570.300.370.300.330.420.420.420.610.660.920.92

Cash Flow & CapEx
Chart
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Cash Flow
-6.04-4.31-7.68-7.31-7.65-8.33-9.42-7.52-7.9-7.99-6.792.66-7.75-9.25-13.08-13.93-11.43-12.36-10.25-10.22
Capital Expenditures
------0.02---------0-0-0.01-0.01-0.36-0.36
Free Cash Flow
-6.04-4.31-7.68-7.31-7.65-8.35-9.42-7.52-7.9-7.99-6.792.66-7.75-9.25-13.08-13.93-11.43-12.37-10.61-10.58
Free Cash Flow Growth
--------------------

Margins
Chart
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Gross Margin
----73.60%-----127.30%-61.89%-------
Operating Margin
-----1950.80%------705.00%--2.11%-------
Pretax Margin
-----2923.20%------964.10%--19.46%-------
Profit Margin
-----2923.20%------910.90%--19.46%-------
FCF Margin
-----1530.20%------678.90%--86.16%-------

Valuation
Chart
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period EndingJun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
PE Ratio
------------------9.91-
PS Ratio
----861.78-----32.34-18.30-------